Evonik Evonik

X

Digital content for Akeso

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Akeso
China Flag
Country
Country
China
Address
Address
No. 6, Shennong Road, Torch Development Zone, Zhongshan City, Guangdong Province 528437
Telephone
Telephone
0760-8987 3998

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/oral-report--the-positive-interim-analysis-results-from-the-phase-iii-clinical-study-of-akesos--cadonilimab-pd-1ctla-4-bsab-plus-chemotherapy-as-first-line-treatment-for-advanced-gastric-cancer-presented-at-2024-aacr-302110917.html

PR NEWSWIRE
08 Apr 2024

https://www.prnewswire.com/news-releases/akeso-announced-the-first-patient-dosed-in-phase-iii-trial-of-cadonilimabpd-1ctla-4-combined-with-chemotherapy-versus-tislelizumab-combined-with-chemotherapy-in-first-line-treatment-of-pd-l1-negative-nsclc-302081234.html

PR NEWSWIRE
06 Mar 2024

https://www.prnewswire.com/news-releases/the-promising-results-of-a-phase-ii-clinical-study-for-akesos-cadonilimab-pd-1ctla-4-combined-standard-treatment-for-first-line-treatment-of-rm-cervical-cancer-has-been-published-in-clinical-cancer-research-302073928.html

PR NEWSWIRE
28 Feb 2024

https://www.prnewswire.com/news-releases/akeso-presented-promising-results-of-cadonilimab-and-lenvatinib-in-combination-with-tace-in-uhcc-at-2024-asco-gi-302041570.html

PR NEWSWIRE
23 Jan 2024

https://www.prnewswire.com/news-releases/akeso-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-and-share-its-corporate--innovative-clinical-development-roadmap-302028539.html

PR NEWSWIRE
08 Jan 2024

https://www.prnewswire.com/news-releases/supplemental-new-drug-application-for-akesos-cadonilimab-pd-1ctla-4-accepted-by-nmpa-for-first-line-treatment-of-gastric-cancer-302027004.html

PR NEWSWIRE
05 Jan 2024

https://www.prnewswire.com/news-releases/akeso-published-results-from-cd47-antibody-ligufalimab-in-combination-with-azacitidine-for-newly-diagnosed-higher-risk-myelodysplastic-syndrome-and-treatment-naive-acute-myeloid-leukemia-at-ash-2023-302016538.html

PR NEWSWIRE
15 Dec 2023

https://www.prnewswire.com/news-releases/results-of-three-investigator-initiated-trials-on-cadonilimab-pd-1ctla-4-for-ggejc-pmmrmss-mcrc-and-hcc-neoadjuvant-therapy-published-at-esmo-asia-2023-302005825.html

PR NEWSWIRE
05 Dec 2023

https://www.biospectrumasia.com/news/26/23402/akeso-invests-rmb-850-m-to-establish-shanghai-global-rd-centre.html

BIOSPECTRUM ASIA
30 Nov 2023

https://www.prnewswire.com/news-releases/akeso-launches-construction-of-shanghai-global-rd-center-to-accelerate-its-innovation-globalization-strategy-301998958.html

PR NEWSWIRE
28 Nov 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY